Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety and Pharmacokinetic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT05721235
What this trial is testing

A Safety/Tolerability and PK Study With Azstarys® in Children With ADHD

Who this might be right for
Attention Deficit/Hyperactivity Disorder
Corium, Inc. 123
Early research (Phase 1)Study completedNCT02423525
What this trial is testing

Safety Study of Afatinib for Brain Cancer

Who this might be right for
Brain Cancer
Santosh Kesari 24
Early research (Phase 1)Study completedNCT02538848
What this trial is testing

Study of HTD4010 in Healthy Volunteers

Who this might be right for
Type 2 Diabetes Mellitus
HighTide Therapeutics (Hong Kong) Limited 32
Early research (Phase 1)Study completedNCT00729950
What this trial is testing

Study of MDX-010 in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma

Who this might be right for
Malignant Melanoma
Bristol-Myers Squibb 92
Early research (Phase 1)WithdrawnNCT03201978
What this trial is testing

Evaluate Pharmacokinetic (PK), Safety and Tolerability of GSK2894512 in Healthy Adult Subjects

Who this might be right for
Psoriasis
GlaxoSmithKline
Large-scale testing (Phase 3)Not Yet RecruitingNCT06841185
What this trial is testing

Compare the Efficacy, Safety, Immunogenicity, and Pharmacokinetic Profile of HLX13 with YERVOY As a First-Line Treatment for Patients with Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Shanghai Henlius Biotech 656
Testing effectiveness (Phase 2)Study completedNCT06391593
What this trial is testing

PD, PK, and Safety of ALTO-203 in Patients With MDD

Who this might be right for
Major Depressive DisorderAnhedonia
Alto Neuroscience 69
Large-scale testing (Phase 3)Study completedNCT02810444
What this trial is testing

Study to Investigate Efficacy, Safety and Pharmacokinetics of BT595 in Subjects With PID

Who this might be right for
Primary Immunodeficiency Disease
Biotest 81
Early research (Phase 1)UnknownNCT02356419
What this trial is testing

RESP Medication With a Single Intravenous Administration and Dose Escalation to Explore the Tolerability ,Safety and Pharmacokinetic Characteristics

Who this might be right for
Chronic Renal Failure
Shenyang Sunshine Pharmaceutical Co., LTD. 40
Testing effectiveness (Phase 2)Looking for participantsNCT07617493
What this trial is testing

Evaluation of ICP-B208 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Beijing InnoCare Pharma Tech Co., Ltd. 539
Early research (Phase 1)Study completedNCT06309667
What this trial is testing

Investigate the Safety, Tolerability, and Pharmacokinetics and Pharmacodynamics Following Subcutaneous Injections of PG-102 (MG12) in Healthy Adult and Obesity Participants.

Who this might be right for
HealthyOverweight
ProGen. Co., Ltd. 102
Early research (Phase 1)Looking for participantsNCT06533332
What this trial is testing

Trial of ERX-315 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Breast CancerMetastatic Ovarian Cancer+3 more
EtiraRx Australia Pty Ltd 36
Testing effectiveness (Phase 2)Study completedNCT04087707
What this trial is testing

Safety, Pharmacokinetic, and Pharmacodynamic Study of TS-142 in Healthy Subjects

Who this might be right for
Healthy Volunteer
Taisho Pharmaceutical Co., Ltd. 23
Early research (Phase 1)Study completedNCT03499444
What this trial is testing

Rucaparib in Japanese Patients With a Previously-treated Solid Tumor

Who this might be right for
Advanced Solid Tumor
pharmaand GmbH 29
Early research (Phase 1)Study completedNCT04075409
What this trial is testing

Test the Safety, and Tolerability of Padsevonil in Healthy Male Japanese Study Participants

Who this might be right for
Healthy Japanese Participants
UCB Biopharma S.P.R.L. 39
Early research (Phase 1)Study completedNCT01284036
What this trial is testing

A Single Dose Study Of The Safety And Investigational Product Level Measurement In Healthy Subjects

Who this might be right for
Healthy
Ablynx, a Sanofi company 63
Testing effectiveness (Phase 2)Study completedNCT02495844
What this trial is testing

UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy

Who this might be right for
Highly Drug-resistant Focal Epilepsy
UCB Biopharma S.P.R.L. 55
Early research (Phase 1)Study completedNCT01478399
What this trial is testing

Pharmacokinetic, Safety/Tolerability Study of a Single SC Dose of PB1023 Injection in Subjects With Normal and Impaired Renal Function

Who this might be right for
Diabetes Mellitus, Type 2
PhaseBio Pharmaceuticals Inc. 16
Early research (Phase 1)Study completedNCT07266207
What this trial is testing

Phase I Study to Evaluate Safety, Tolerability, Pharmacokinetic, and Food Effects of ARD-885 Film-coated Tablets in Healthy Chinese Subjects and Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis (RA)
Artivila (Shenzhen) Innovation Center, Ltd 94
Testing effectiveness (Phase 2)Study completedNCT01163149
What this trial is testing

Safety and Efficacy Study of Asfotase Alfa in Adolescents and Adults With Hypophosphatasia (HPP)

Who this might be right for
Hypophosphatasia
Alexion Pharmaceuticals, Inc. 19
Next Page